» Articles » PMID: 23823215

Eroticization As a Factor Influencing Erectile Dysfunction Treatment Effectiveness

Overview
Journal Int J Impot Res
Date 2013 Jul 5
PMID 23823215
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We review both the medical and psychosocial literature on factors influencing male potency in order to better understand why erectile dysfunction (ED) treatments, PDE5 drugs in particular, are abandoned when otherwise effective. We incorporate anecdotal data from websites and list serves dedicated to helping patients deal with iatrogenic ED. Our goal is to distinguish between ED treatments that are medicalized versus eroticized, and how partner participation may influence their effectiveness. Recently it has been shown that ED treatment effectiveness is aided by the involvement of the patient's partner. This permits an erotic association between the partner and the ED 'aid'. We extend this idea to suggest that having the partner involved as early as possible in the discussion of treatment, and their presence at the time of prescription, should improve ED aid effectiveness. Eroticization of ED aids shifts the focus from a perceived disability of the patient toward the sexual pleasure provided by the partner. We further suggest that ED aids used without the partner's knowledge will undermine intimacy and ultimately the treatment's effectiveness. Unpartnered patients should be advised about the importance of informing potential partners about their use of such aids, as openness and honesty may increase intimacy in the long run.

Citing Articles

Patient Reported Sexual Adaptation Following Prostate Cancer Treatment: An Analysis of Related Variables and Sexual Outcomes Associated with Sexual Adaptation Styles.

Shah F, MacLeod F, Walker L Arch Sex Behav. 2024; 53(6):2377-2395.

PMID: 38609584 DOI: 10.1007/s10508-024-02855-z.


Psychosocial contributors to patients' and partners' postprostate cancer sexual recovery: 10 evidence-based and practical considerations.

Walker L Int J Impot Res. 2020; 33(4):464-472.

PMID: 33204005 DOI: 10.1038/s41443-020-00369-5.


Revisiting the Regenerative Therapeutic Advances Towards Erectile Dysfunction.

Liu M, Chang M, Wang Y, Chen W, Wu C, Yeh S Cells. 2020; 9(5).

PMID: 32438565 PMC: 7290763. DOI: 10.3390/cells9051250.


Recent advances in the understanding and management of erectile dysfunction.

Krzastek S, Bopp J, Smith R, Kovac J F1000Res. 2019; 8.

PMID: 30740217 PMC: 6348436. DOI: 10.12688/f1000research.16576.1.


Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction.

Wassersug R, Wibowo E Transl Androl Urol. 2017; 6(Suppl 5):S776-S794.

PMID: 29238658 PMC: 5715194. DOI: 10.21037/tau.2017.04.09.


References
1.
Elliott S, Latini D, Walker L, Wassersug R, Robinson J . Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med. 2010; 7(9):2996-3010. DOI: 10.1111/j.1743-6109.2010.01902.x. View

2.
Rot I, Ogah I, Wassersug R . The language of prostate cancer treatments and implications for informed decision making by patients. Eur J Cancer Care (Engl). 2012; 21(6):766-75. DOI: 10.1111/j.1365-2354.2012.01359.x. View

3.
Barry M, Gallagher P, Skinner J, Fowler Jr F . Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol. 2012; 30(5):513-8. PMC: 3295553. DOI: 10.1200/JCO.2011.36.8621. View

4.
Pascoal P, Narciso I, Pereira N . Emotional intimacy is the best predictor of sexual satisfaction of men and women with sexual arousal problems. Int J Impot Res. 2012; 25(2):51-5. DOI: 10.1038/ijir.2012.38. View

5.
Brody S . The relative health benefits of different sexual activities. J Sex Med. 2010; 7(4 Pt 1):1336-61. DOI: 10.1111/j.1743-6109.2009.01677.x. View